Skip to main content
Top
Published in: Drug Safety 1/2013

01-01-2013 | Original Research Article

Opportunities to Reduce Medication Regimen Complexity

A Retrospective Analysis of Patients Discharged from a University Hospital in Germany

Authors: Diana Witticke, Hanna M. Seidling, Kristina Lohmann, Alexander F. J. Send, Walter E. Haefeli

Published in: Drug Safety | Issue 1/2013

Login to get access

Abstract

Background

Numerous characteristics of a medication regimen can weaken patient adherence to drug therapy and thus impair clinical outcomes of drug therapy.

Objective

The aim of the study was to investigate the prevalence of medication regimen characteristics that are known to reduce patient adherence to drug therapy. Furthermore, we assessed to what extent complex medication regimens can possibly be simplified through different strategies.

Methods

We retrospectively evaluated the medication regimens of 500 consecutive patients discharged from the University Hospital of Heidelberg, Germany, in whom the dosages of all drugs were specified. The medication regimens were extracted from the discharge letters issued between 1 January 2007 and 29 December 2007. Each medication regimen was checked for the presence of seven regimen characteristics that are known to reduce patient adherence, and theoretical viable strategies to avoid four of the respective characteristics were identified. The extent of possible simplification through the identified strategies was evaluated for the overall study population and the subgroup of elderly patients (≥65 years) with polypharmacy (≥5 drugs).

Results

On average, every medication regimen in the overall study population had 2.9 ± 1.7 (standard deviation) characteristics (range 0–7) known to impair patient adherence. In contrast, the medication regimens of elderly patients with polypharmacy contained 3.7 ± 1.6 characteristics (range 0–7) known to impair patient adherence. The most prevalent complexity characteristics in the overall study population were prescription of ≥1 drug with multiple doses per day (441 patients), ≥3 drugs with different dosing intervals (349 patients), tablet splitting (223 patients), followed by ≥12 daily drug administrations (190 patients). Almost half of the prescribed tablet splitting could be prevented. Moreover, 17.9 % of the multi-dose prescriptions could be switched to once-daily dosing, and thus reduced the number of drugs with different dosing intervals and the number of daily drug administrations. The combined intervention reduced the total number of potentially preventable complexity characteristics by 18.3 % (from 2283 to 1865 characteristics) without reducing prescription quality.

Conclusion

Almost one-fifth of all regimen complexity characteristics relevant for patient adherence were avoidable by simple modifications of the medication scheme, stressing the need for targeted interventions.
Literature
1.
go back to reference Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20(10):1512–7.PubMedCrossRef Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20(10):1512–7.PubMedCrossRef
2.
go back to reference Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944–50.PubMedCrossRef Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944–50.PubMedCrossRef
3.
go back to reference Huas D, Debiais F, Blotman F, et al. Compliance and treatment satisfaction of post menopausal women treated for osteoporosis: compliance with osteoporosis treatment. BMC Womens Health. 2010;10:26.PubMedCrossRef Huas D, Debiais F, Blotman F, et al. Compliance and treatment satisfaction of post menopausal women treated for osteoporosis: compliance with osteoporosis treatment. BMC Womens Health. 2010;10:26.PubMedCrossRef
4.
go back to reference Carlson MC, Fried LP, Xue QL, et al. Validation of the Hopkins Medication Schedule to identify difficulties in taking medications. J Gerontol A Biol Sci Med Sci. 2005;60(2):217–23.PubMedCrossRef Carlson MC, Fried LP, Xue QL, et al. Validation of the Hopkins Medication Schedule to identify difficulties in taking medications. J Gerontol A Biol Sci Med Sci. 2005;60(2):217–23.PubMedCrossRef
5.
go back to reference Crentsil V, Ricks MO, Xue QL, et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother. 2010;8(3):215–24.PubMedCrossRef Crentsil V, Ricks MO, Xue QL, et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother. 2010;8(3):215–24.PubMedCrossRef
6.
go back to reference Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–44.PubMedCrossRef Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–44.PubMedCrossRef
7.
go back to reference Jorgensen T, Johansson S, Kennerfalk A, et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35(9):1004–9.PubMedCrossRef Jorgensen T, Johansson S, Kennerfalk A, et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35(9):1004–9.PubMedCrossRef
8.
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–17.PubMedCrossRef Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–17.PubMedCrossRef
9.
go back to reference Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl. 2):171–6.CrossRef Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl. 2):171–6.CrossRef
10.
go back to reference Lam PW, Lum CM, Leung MF. Drug non-adherence and associated risk factors among Chinese geriatric patients in Hong Kong. Hong Kong Med J. 2007;13(4):284–92.PubMed Lam PW, Lum CM, Leung MF. Drug non-adherence and associated risk factors among Chinese geriatric patients in Hong Kong. Hong Kong Med J. 2007;13(4):284–92.PubMed
11.
go back to reference Frohlich SE, Zaccolo AV, da Silva SL, et al. Association between drug prescribing and quality of life in primary care. Pharm World Sci. 2010;32(6):744–51.PubMedCrossRef Frohlich SE, Zaccolo AV, da Silva SL, et al. Association between drug prescribing and quality of life in primary care. Pharm World Sci. 2010;32(6):744–51.PubMedCrossRef
12.
go back to reference Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28(2):124–31.PubMed Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28(2):124–31.PubMed
13.
go back to reference Muir AJ, Sanders LL, Wilkinson WE, et al. Reducing medication regimen complexity: a controlled trial. J Gen Intern Med. 2001;16(2):77–82.PubMedCrossRef Muir AJ, Sanders LL, Wilkinson WE, et al. Reducing medication regimen complexity: a controlled trial. J Gen Intern Med. 2001;16(2):77–82.PubMedCrossRef
14.
go back to reference George J, Phun YT, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76.PubMedCrossRef George J, Phun YT, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76.PubMedCrossRef
15.
go back to reference Huang ES, Basu A, Finch M, et al. The complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003. Curr Med Res Opin. 2007;23(6):1423–30.PubMedCrossRef Huang ES, Basu A, Finch M, et al. The complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003. Curr Med Res Opin. 2007;23(6):1423–30.PubMedCrossRef
16.
go back to reference Martin S, Wolters PL, Calabrese SK, et al. The Antiretroviral Regimen Complexity Index: a novel method of quantifying regimen complexity. J Acquir Immune Defic Syndr. 2007;45(5):535–44.PubMedCrossRef Martin S, Wolters PL, Calabrese SK, et al. The Antiretroviral Regimen Complexity Index: a novel method of quantifying regimen complexity. J Acquir Immune Defic Syndr. 2007;45(5):535–44.PubMedCrossRef
17.
go back to reference Corsonello A, Pedone C, Lattanzio F, et al. Regimen complexity and medication nonadherence in elderly patients. Ther Clin Risk Manag. 2009;5(1):209–16.PubMedCrossRef Corsonello A, Pedone C, Lattanzio F, et al. Regimen complexity and medication nonadherence in elderly patients. Ther Clin Risk Manag. 2009;5(1):209–16.PubMedCrossRef
18.
go back to reference Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;15(31 Suppl 3):123–7.CrossRef Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;15(31 Suppl 3):123–7.CrossRef
19.
go back to reference Maggiolo F, Ripamonti D, Suter F. Once-a-day HAART: dream or reality? HIV Clin Trials. 2003;4(3):193–201.PubMedCrossRef Maggiolo F, Ripamonti D, Suter F. Once-a-day HAART: dream or reality? HIV Clin Trials. 2003;4(3):193–201.PubMedCrossRef
20.
go back to reference Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.PubMedCrossRef Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.PubMedCrossRef
21.
go back to reference Field TS, Mazor KM, Briesacher B, et al. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007;55(2):271–6.PubMedCrossRef Field TS, Mazor KM, Briesacher B, et al. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007;55(2):271–6.PubMedCrossRef
22.
go back to reference Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, et al. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study. Br J Clin Pharmacol. 2011;71(5):766–76.PubMedCrossRef Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, et al. Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study. Br J Clin Pharmacol. 2011;71(5):766–76.PubMedCrossRef
23.
go back to reference Dragomir A, Cote R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–25.PubMedCrossRef Dragomir A, Cote R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–25.PubMedCrossRef
24.
go back to reference Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881–4.PubMedCrossRef Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881–4.PubMedCrossRef
25.
go back to reference Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.PubMedCrossRef Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.PubMedCrossRef
26.
go back to reference Maitland D, Jackson A, Osorio J, et al. Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy. HIV Med. 2008;9(8):667–72.PubMedCrossRef Maitland D, Jackson A, Osorio J, et al. Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy. HIV Med. 2008;9(8):667–72.PubMedCrossRef
27.
go back to reference Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273–7.PubMedCrossRef Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273–7.PubMedCrossRef
28.
go back to reference McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–79.PubMedCrossRef McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–79.PubMedCrossRef
29.
go back to reference Kardas P. Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial. Vasc Health Risk Manag. 2007;3(2):235–42.PubMedCrossRef Kardas P. Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial. Vasc Health Risk Manag. 2007;3(2):235–42.PubMedCrossRef
30.
go back to reference Saini SD, Schoenfeld P, Kaulback K, et al. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15(6):E22–33.PubMed Saini SD, Schoenfeld P, Kaulback K, et al. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15(6):E22–33.PubMed
31.
go back to reference Murri R, Cingolani A, De Luca A, et al. Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. J Acquir Immune Defic Syndr. 2010;55(3):411–2.PubMedCrossRef Murri R, Cingolani A, De Luca A, et al. Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. J Acquir Immune Defic Syndr. 2010;55(3):411–2.PubMedCrossRef
32.
go back to reference Johnson M, Griffiths R, Piper M, et al. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nurs. 2005;22(1):36–44.PubMedCrossRef Johnson M, Griffiths R, Piper M, et al. Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nurs. 2005;22(1):36–44.PubMedCrossRef
33.
go back to reference Eldred LJ, Wu AW, Chaisson RE, et al. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(2):117–25.PubMedCrossRef Eldred LJ, Wu AW, Chaisson RE, et al. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(2):117–25.PubMedCrossRef
34.
go back to reference Hixson-Wallace JA, Dotson JB, Blakey SA. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost. 2001;7(1):33–7.PubMedCrossRef Hixson-Wallace JA, Dotson JB, Blakey SA. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost. 2001;7(1):33–7.PubMedCrossRef
35.
go back to reference Kaiser RM, Schmader KE, Pieper CF, et al. Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging. 2006;23(7):579–86.PubMedCrossRef Kaiser RM, Schmader KE, Pieper CF, et al. Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging. 2006;23(7):579–86.PubMedCrossRef
36.
go back to reference Quinzler R, Schmitt SP, Pritsch M, et al. Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm. BMC Med Inform Decis Mak. 2009;9:30.PubMedCrossRef Quinzler R, Schmitt SP, Pritsch M, et al. Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm. BMC Med Inform Decis Mak. 2009;9:30.PubMedCrossRef
37.
go back to reference Quinzler R, Gasse C, Schneider A, et al. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62(12):1065–73.PubMedCrossRef Quinzler R, Gasse C, Schneider A, et al. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62(12):1065–73.PubMedCrossRef
38.
go back to reference Rodenhuis N, De Smet PA, Barends DM. The rationale of scored tablets as dosage form. Eur J Pharm Sci. 2004;21(2–3):305–8.PubMedCrossRef Rodenhuis N, De Smet PA, Barends DM. The rationale of scored tablets as dosage form. Eur J Pharm Sci. 2004;21(2–3):305–8.PubMedCrossRef
39.
go back to reference Atkin PA, Finnegan TP, Ogle SJ, et al. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing. 1994;23(2):113–6.PubMedCrossRef Atkin PA, Finnegan TP, Ogle SJ, et al. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing. 1994;23(2):113–6.PubMedCrossRef
40.
go back to reference McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy. 1998;18(1):193–7.PubMed McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy. 1998;18(1):193–7.PubMed
41.
go back to reference Cook TJ, Edwards S, Gyemah C, et al. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. J Am Pharm Assoc (2003). 2004;44(5):583–6.CrossRef Cook TJ, Edwards S, Gyemah C, et al. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. J Am Pharm Assoc (2003). 2004;44(5):583–6.CrossRef
42.
go back to reference Rosenberg JM, Nathan JP, Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J Am Pharm Assoc (Wash). 2002;42(2):200–5.CrossRef Rosenberg JM, Nathan JP, Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J Am Pharm Assoc (Wash). 2002;42(2):200–5.CrossRef
43.
go back to reference Hill SW, Varker AS, Karlage K, et al. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2009;15(3):253–61.PubMed Hill SW, Varker AS, Karlage K, et al. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2009;15(3):253–61.PubMed
44.
go back to reference Margiocco ML, Warren J, Borgarelli M, et al. Analysis of weight uniformity, content uniformity and 30-day stability in halves and quarters of routinely prescribed cardiovascular medications. J Vet Cardiol. 2009;11(1):31–9.PubMedCrossRef Margiocco ML, Warren J, Borgarelli M, et al. Analysis of weight uniformity, content uniformity and 30-day stability in halves and quarters of routinely prescribed cardiovascular medications. J Vet Cardiol. 2009;11(1):31–9.PubMedCrossRef
45.
go back to reference Gupta P, Gupta K. Broken tablets: does the sum of the parts equal the whole [letter]? Am J Hosp Pharm. 1988;45(7):1498.PubMed Gupta P, Gupta K. Broken tablets: does the sum of the parts equal the whole [letter]? Am J Hosp Pharm. 1988;45(7):1498.PubMed
46.
go back to reference Hamer AM, Hartung DM, Haxby DG, et al. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program. J Manag Care Pharm. 2006;12(6):449–56.PubMed Hamer AM, Hartung DM, Haxby DG, et al. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program. J Manag Care Pharm. 2006;12(6):449–56.PubMed
47.
go back to reference Fawell NG, Cookson TL, Scranton SS. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm. 1999;56(24):2542–5.PubMed Fawell NG, Cookson TL, Scranton SS. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. Am J Health Syst Pharm. 1999;56(24):2542–5.PubMed
48.
go back to reference Ramos-Quiroga JA, Bosch R, Castells X, et al. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs. 2008;22(7):603–11.PubMedCrossRef Ramos-Quiroga JA, Bosch R, Castells X, et al. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs. 2008;22(7):603–11.PubMedCrossRef
49.
go back to reference Doesch AO, Mueller S, Konstandin M, et al. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Transplant Proc. 2010;42(10):4238–42.PubMedCrossRef Doesch AO, Mueller S, Konstandin M, et al. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Transplant Proc. 2010;42(10):4238–42.PubMedCrossRef
50.
go back to reference Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713–9.PubMedCrossRef Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713–9.PubMedCrossRef
51.
go back to reference Thayer S, Arondekar B, Harley C, et al. Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. Ann Pharmacother. 2010;44(5):791–9.PubMedCrossRef Thayer S, Arondekar B, Harley C, et al. Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. Ann Pharmacother. 2010;44(5):791–9.PubMedCrossRef
52.
go back to reference DiIorio C, Yeager K, Shafer PO, et al. The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155–62.PubMedCrossRef DiIorio C, Yeager K, Shafer PO, et al. The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155–62.PubMedCrossRef
53.
go back to reference Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.PubMedCrossRef Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.PubMedCrossRef
Metadata
Title
Opportunities to Reduce Medication Regimen Complexity
A Retrospective Analysis of Patients Discharged from a University Hospital in Germany
Authors
Diana Witticke
Hanna M. Seidling
Kristina Lohmann
Alexander F. J. Send
Walter E. Haefeli
Publication date
01-01-2013
Publisher
Springer International Publishing AG
Published in
Drug Safety / Issue 1/2013
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-012-0007-5

Other articles of this Issue 1/2013

Drug Safety 1/2013 Go to the issue